スポンサーリンク

Department of Blood and Marrow Transplantation, Moffitt Cancer Center | 論文

• Targeted IV busulfan and fludarabine followed by post-allogeneic hematopoietic cell transplantation rituximab demonstrate encouraging activity in CD20+ lymphoid malignancies without increased risk of infectious complications

スポンサーリンク